Market revenue in 2023 | USD 243.2 million |
Market revenue in 2030 | USD 363.4 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Lateral Flow Readers |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche, Bio-Rad Laboratories Inc, BioMerieux SA, QuidelOrtho Corp, Hologic Inc, PerkinElmer, Merck KGaA, BD, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lateral flow assays market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.02% in 2023. Horizon Databook has segmented the India lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to 2030.
An increase in awareness campaigns conducted by leading market players is expected to fuel the market during the forecast period. In January 2019, Abbott announced its support for the partnership between the Malaria No More initiative and government of Odisha by providing expertise, technology, & funds to curb malaria in the state.
In this campaign, Abbott distributed around 1 million rapid diagnostic tests, a contribution of USD 750,000, as well as expertise to strengthen Odisha’s malaria detection system. Such initiatives are expected to facilitate development of various novel technologies and improve market penetration.
An increase in the number of awareness campaigns by leading market players is anticipated to fuel market growth. For instance, the Indian government’s National Strategic Plan (NSP) for Malaria Elimination (2017-2022) is taking efforts to increase awareness and eliminate malaria in the country by 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the India lateral flow assays market , including forecasts for subscribers. This country databook contains high-level insights into India lateral flow assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account